RESUMO
Carboxymaltose iron (Ferinject®) is a formulation for intravenous (iv) administration, used for the treatment of iron deficiency anemia and/or iron deficiency when oral administration of iron is not effective or due to intolerance. Its safety profile is excellent with few, but not nonexistent, side effects. Hypophosphatemia has been described as one of them. It is usually mild, transient and asymptomatic. However, in some cases it may be accompanied by nausea, asthenia, in addition to muscular and neurological symptoms and hematological alterations. It is, therefore, a potentially serious adverse effect whose prevalence is unknown and which requires high clinical suspicion to be detected.
Assuntos
Hipofosfatemia , Osteomalacia , Compostos Férricos , Humanos , Hipofosfatemia/induzido quimicamente , Hipofosfatemia/tratamento farmacológico , Hipofosfatemia/epidemiologia , Ferro/efeitos adversos , Maltose/efeitos adversos , Maltose/análogos & derivados , Osteomalacia/induzido quimicamente , Osteomalacia/tratamento farmacológicoRESUMO
We present the case of an 81-year-old male with a history of surgically resected colorectal and bladder cancer, who was admitted to our hospital with a urinary infection. A routine renal ultrasound showed a pelvic cyst and a CT scan confirmed a non-complicated cyst, but a lesion was observed in the left lung. He underwent a PET-CT in which an unexpected enhancement of the small bowel attracted our attention.
Assuntos
Adenocarcinoma , Neoplasias Duodenais , Adenocarcinoma/diagnóstico por imagem , Adenocarcinoma/cirurgia , Idoso de 80 Anos ou mais , Neoplasias Duodenais/diagnóstico por imagem , Neoplasias Duodenais/cirurgia , Duodeno , Humanos , Masculino , Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada , UltrassonografiaRESUMO
Schwannomas are benign tumors derived from the Schwann cells of the neural sheath. Their incidence in the digestive tract is very low and generally occurs in the stomach, colon and rectum. Duodenal schwannoma is even rarer.